Microbiome Sequencing Methods for Studying Human Diseases.

Over the last decade, biologists have come to appreciate that the human body is inhabited by thousands of bacterial species in diverse communities unique to each body site. Moreover, due to high-throughput sequencing methods for microbial characterization in a culture-independent manner, it is becoming evident that the microbiome plays an important role in human health and disease. This chapter focuses on the most common form of bacterial microbiome profiling, targeted amplicon sequencing of the 16S ribosomal RNA (rRNA) subunit encoded by 16S rDNA. We discuss important features for designing and performing microbiome experiments on human specimens, including experimental design, sample collection, DNA preparation, and selection of the 16S rDNA sequencing target. We also provide details for designing fusion primers required for targeted amplicon sequencing and selecting the most appropriate high-throughput sequencing platform. We conclude with a review of the fundamental concepts of data analysis and interpretation for these kinds of experiments. Our goal is to provide the reader with the essential knowledge needed to undertake microbiome experiments for application to human disease research questions.

[1]  A. Fodor,et al.  Analysis of Changes in Diversity and Abundance of the Microbial Community in a Cystic Fibrosis Patient over a Multiyear Period , 2014, Journal of Clinical Microbiology.

[2]  Andreas Wilke,et al.  The Biological Observation Matrix (BIOM) format or: how I learned to stop worrying and love the ome-ome , 2012, GigaScience.

[3]  J. Ravel,et al.  Evaluation of Methods for the Extraction and Purification of DNA from the Human Microbiome , 2012, PloS one.

[4]  Sumio Watanabe,et al.  Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis , 2017, Inflammatory bowel diseases.

[5]  Gregory B Gloor,et al.  Expanding the UniFrac Toolbox , 2016, PloS one.

[6]  E. Rosser,et al.  A clinical update on the significance of the gut microbiota in systemic autoimmunity. , 2016, Journal of autoimmunity.

[7]  G. Huffnagle Another piece in the ‘research mosaic’ that describes the role of the lung microbiome in COPD , 2016, Thorax.

[8]  Emily S. Charlson,et al.  Minimum information about a marker gene sequence (MIMARKS) and minimum information about any (x) sequence (MIxS) specifications , 2011, Nature Biotechnology.

[9]  Yong Wang,et al.  Sensitivity and correlation of hypervariable regions in 16S rRNA genes in phylogenetic analysis , 2016, BMC Bioinformatics.

[10]  Geoffrey D. Hannigan,et al.  Skin Microbiome Surveys Are Strongly Influenced by Experimental Design. , 2016, The Journal of investigative dermatology.

[11]  G. Pluschke,et al.  Optimized DNA preparation from mycobacteria. , 2010, Cold Spring Harbor protocols.

[12]  V. Tremaroli,et al.  Linking Microbiota to Human Diseases: A Systems Biology Perspective , 2015, Trends in Endocrinology & Metabolism.

[13]  Angela C. Poole,et al.  Human Genetics Shape the Gut Microbiome , 2014, Cell.

[14]  Martin Hartmann,et al.  Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities , 2009, Applied and Environmental Microbiology.

[15]  Katherine H. Huang,et al.  A framework for human microbiome research , 2012, Nature.

[16]  M. Noval Rivas,et al.  The microbiome in asthma , 2016, Current opinion in pediatrics.

[17]  Anthony O'Donnell,et al.  Microbial 16S rRNA Ion Tag and community metagenome sequencing using the Ion Torrent (PGM) Platform. , 2012, Journal of microbiological methods.

[18]  Eoin L. Brodie,et al.  Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients , 2010, PloS one.

[19]  K. Honda,et al.  The microbiome in infectious disease and inflammation. , 2012, Annual review of immunology.

[20]  Zaid Abdo,et al.  The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation , 2015, Microbiome.

[21]  D. Stanley,et al.  Experimental design considerations in microbiota/inflammation studies , 2016, Clinical & translational immunology.

[22]  V. Young,et al.  The microbiome of the lung. , 2012, Translational research : the journal of laboratory and clinical medicine.

[23]  Paul Turner,et al.  Reagent and laboratory contamination can critically impact sequence-based microbiome analyses , 2014, BMC Biology.

[24]  K. Dąbrowska,et al.  Correlations of Host Genetics and Gut Microbiome Composition , 2016, Front. Microbiol..

[25]  Katherine H. Huang,et al.  Host genetic variation impacts microbiome composition across human body sites , 2015, Genome Biology.

[26]  Rob Knight,et al.  The Earth Microbiome project: successes and aspirations , 2014, BMC Biology.

[27]  R. Knight,et al.  The Human Microbiome Project , 2007, Nature.

[28]  G. Weinstock,et al.  The importance of the microbiome in epidemiologic research. , 2016, Annals of epidemiology.

[29]  Sarah L. Westcott,et al.  Development of a Dual-Index Sequencing Strategy and Curation Pipeline for Analyzing Amplicon Sequence Data on the MiSeq Illumina Sequencing Platform , 2013, Applied and Environmental Microbiology.

[30]  William A. Walters,et al.  Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms , 2012, The ISME Journal.

[31]  D. Alland,et al.  A detailed analysis of 16S ribosomal RNA gene segments for the diagnosis of pathogenic bacteria. , 2007, Journal of microbiological methods.

[32]  B. Snel,et al.  Toward Automatic Reconstruction of a Highly Resolved Tree of Life , 2006, Science.

[33]  Se Jin Song,et al.  Tracking down the sources of experimental contamination in microbiome studies , 2014, Genome Biology.

[34]  William A. Walters,et al.  Conducting a Microbiome Study , 2014, Cell.

[35]  Andrew J. Oler,et al.  Development of an Analysis Pipeline Characterizing Multiple Hypervariable Regions of 16S rRNA Using Mock Samples , 2016, PloS one.

[36]  P. Bork,et al.  Enterotypes of the human gut microbiome , 2011, Nature.

[37]  Katherine H. Huang,et al.  Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.

[38]  R. Knight,et al.  UniFrac: an effective distance metric for microbial community comparison , 2011, The ISME Journal.

[39]  S. Donaldson,et al.  Lung microbiota across age and disease stage in cystic fibrosis , 2015, Scientific Reports.

[40]  Susan Holmes,et al.  phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data , 2013, PloS one.

[41]  J. Jansson,et al.  Changes in the Composition of the Human Fecal Microbiome After Bacteriotherapy for Recurrent Clostridium difficile-associated Diarrhea , 2009, Journal of clinical gastroenterology.

[42]  J. Harris,et al.  Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods. , 2015, Annals of the American Thoracic Society.

[43]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[44]  Marcus J. Claesson,et al.  Comparison of two next-generation sequencing technologies for resolving highly complex microbiota composition using tandem variable 16S rRNA gene regions , 2010, Nucleic acids research.

[45]  Leah M. Feazel,et al.  Opportunistic pathogens enriched in showerhead biofilms , 2009, Proceedings of the National Academy of Sciences.

[46]  M. Pop,et al.  Metagenomic Assembly: Overview, Challenges and Applications , 2016, The Yale journal of biology and medicine.

[47]  J. Raes,et al.  Heterogeneity of the gut microbiome in mice: guidelines for optimizing experimental design , 2015, FEMS microbiology reviews.

[48]  C. Bertelli,et al.  Rapid bacterial genome sequencing: methods and applications in clinical microbiology. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.